Summary
Furosemide produces in man a renal loss of sodium, chloride, calcium, magnesium and to a small extent potassium, its actions therefore are not ion specific. Furosemide has been shown to inhibit active chloride reabsorption in the thick ascending limb of Henle's loop in rabbits and this appears to be its major pharmacological effect.
Furosemide has the following biochemical actions on the isolated toad bladder, a membrane exhibiting vasopressin stimulable active sodium transport, an effect mediated by cAMP. It displaces cyclic AMP from specific cyclic AMP binding protein, it also inhibits the phosphorylation of histones by a cAMP dependent protein kinase, these effects require 6×10−4 M frusemide. Furosemide has no effect on resting or hormone stimulated levels of cAMP in toad bladder cells, though ethacrynic acid reduces both. Ethacrynic acid has no effect on the cAMP dependent mechanisms affected by furosemide.
From these results we conclude that the biochemical link between furosemide and ethacrynic acid is their effects on cAMP mechanisms. We know renal calcium handling mechanisms are cAMP dependent, is cAMP implicated in renal handling of chloride and sodium?
Similar content being viewed by others
References
Anderton, J. L., Kincaid-Smith, P.: Diuretics I: Physiological and pharmacological considerations. Drugs 1, 54–81 (1971)
Bentley, P. J.: Actions of vasopressin and aldosterone on the toad bladder: inhibition by ethacrynic acid. J. Endocr. 43, 347–357 (1969)
Burg, M., Stoner, L., Cardinal, J., Green, N.: Furosemide effect on isolated perfused tubules. (In press)
Chase, L. R., Aurbach, G. D.: Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science 159, 545–547 (1968)
Cooper, R. H., McPherson, M., Schofield, J. G.: The effect of prostaglandins on ox pituitary content of adenosine 3′5′-cyclic monophosphate and the release of growth hormone. Biochem. J. 127, 143–154 (1972)
Ferguson, D. R.: Effects of frusemide on sodium and water transport by the isolated toad bladder. Brit. J. Pharmacol. 27, 528–531 (1966)
Ferguson, D. R., Smith, M. W.: Direct measurement of sodium uptake by toad bladder mucosal cells. J. Endocr. 55, 195–201 (1972)
Ferguson, D. R., Twite, B. R.: Inhibition by diuretics of cyclic 3′-5′-AMP dependent protein kinase from toad bladder epithelium. Brit. J. Pharmacol. (in press)
Gilman, A. G.: A protein binding assay for adenosine 3′5′-cyclic monophosphate Proc. nat. Acad. Sci. (Wash.) 67, 305–312 (1970)
Handler, J. S., Preston, A. S., Rogulski, J.: Control of glycogenolysis in the toad's urinary bladder. J. biol. Chem. 243, 1376–1383 (1968)
Hänze, S., Seyberth, H.: Untersuchungen zur Wirkung der Diuretica Furosemid, Etacrynsäure und Triamteren auf die renale Magnesium- und Calciumaus-scheidung. Klin. Wschr. 45, 313–314 (1967)
Holzgreve, H.: Klinische Pharmacologie der Diuretica. Internist 12, Suppl. 2, 337–345 (1971)
Landon, E.J.: Interaction of diuretics with thiols and cell membranes in renal tubules. Biological Council Symposium: Drugs and Transport Processes, London 1973
Lorenzo, R. J. de, Walton, K. G., Curran, P. F., Greengard, P.: Regulation of phosphorylation of a specific protein in toad bladder membrane by antidiuretic hormone and cyclic AMP, and its possible relationship to membrane permeability changes. Proc. nat. Acad. Sci. (Wash.) 70, 880–884 (1973)
Mendoza, S. A., Handler, J. S., Orloff, J.: Effect of inhibitors of sodium transport on response of toad bladder to ADH and cyclic AMP. Amer. J. Physiol. 219, 1440–1445 (1970)
Seldin, D. W., Eknoyan, G., Suki, W., Rector, F. C.: The physiology of modern diuretics. Proc. 3rd Int. Congr. Nephrol. Washington, Vol. 1, pp. 240–249. Basel-New York: Karger 1966
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferguson, D.R., Twite, B.R. Furosemide — Pharmacology and cellular mode of action. Naunyn-Schmiedeberg's Arch. Pharmacol. 281, 295–300 (1974). https://doi.org/10.1007/BF00500598
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00500598